封面
市场调查报告书
商品编码
1982907

全球人工器官市场规模、份额、趋势和成长分析报告(2026-2034年)

Global Artificial Organs Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 145 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计人造器官市场将从 2025 年的 346.4 亿美元成长到 2034 年的 708.1 亿美元,2026 年至 2034 年的复合年增长率为 8.27%。

随着医疗技术的进步,全球人工器官市场正在不断扩大,以满足日益增长的器官替代疗法需求。人工器官是一种旨在模拟心臟、肾臟和肺部等天然器官功能的医疗设备。这些器械用于帮助器官衰竭或患有严重慢性疾病的患者。

多种因素正在推动这一市场的成长。器官衰竭的日益普遍和捐赠器官的短缺,使得人工器官技术的需求强劲。此外,生物医学工程和医疗设备製造技术的进步,也提高了人工器官的性能和安全性。

由于持续的研究不断提升设备的功能性和生物相容性,人工器官市场被认为极具发展前景。增加对医疗创新和再生医学的投资,可望推动更先进的人工器官系统的研发。随着医疗技术的进步,人工器官预计将在拯救生命的治疗中发挥日益关键的作用。

目录

第一章:引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章:全球人工器官市场:依器官类型划分

  • 市场分析、洞察与预测
  • 人工心臟
  • 人工心臟瓣膜
  • 心室辅助装置
  • 心臟起搏器
  • 人工肾臟
  • 人工胰臟
  • 人工肺
  • 人工电子耳
  • 人工肝臟
  • 其他的

第五章:全球人工器官市场:依材料类型划分

  • 市场分析、洞察与预测
  • 塑胶

第六章:全球人工器官市场:依类型划分

  • 市场分析、洞察与预测
  • 永久性人工器官
  • 临时人工器官

第七章 全球人工器官市场:依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴(根据现有资讯)
  • 市场占有率和市场定位分析(基于现有资讯)
  • 供应商情况(基于现有资讯)
  • 策略规划

第九章:公司简介

  • 主要公司的市占率分析
  • 公司简介
    • B. Braun SE
    • Boston Scientific Corporation
    • Getinge AB
    • Abiomed
    • Asahi Kasei Corporation
    • Berlin Heart
    • Carmat
    • Jarvik Heart Inc
    • Terumo Corporation
    • SynCardia Systems LLC
    • Nipro Europe Group Companies
简介目录
Product Code: VMR11212966

The Artificial Organs Market size is expected to reach USD 70.81 Billion in 2034 from USD 34.64 Billion (2025) growing at a CAGR of 8.27% during 2026-2034.

The global artificial organs market is expanding as medical technology advances to address the growing demand for organ replacement therapies. Artificial organs are medical devices designed to replicate the function of natural organs such as the heart, kidneys, and lungs. These devices are used to support patients who suffer from organ failure or severe chronic diseases.

Several factors are driving the growth of this market. The increasing prevalence of organ failure and the shortage of donor organs are creating strong demand for artificial organ technologies. Additionally, advancements in biomedical engineering and medical device manufacturing are improving the performance and safety of artificial organs.

The future prospects of the artificial organs market appear highly promising as research continues to improve device functionality and compatibility with the human body. Increasing investments in healthcare innovation and regenerative medicine may lead to the development of more advanced artificial organ systems. As medical technology progresses, artificial organs are expected to play an increasingly important role in life-saving treatments.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Organ Type

  • Artificial Heart
  • Prosthetic Heart Valves
  • Ventricular Assist Devices
  • Cardiac Pacemakers
  • Artificial Kidney
  • Artificial Pancreas
  • Artificial Lungs
  • Cochlear Implants
  • Artificial Liver
  • Others

By Material Type

  • Silicon
  • Plastics
  • Steel

By Type

  • Permanent Artificial Organs
  • Temporary Artificial Organs

COMPANIES PROFILED

  • B Braun SE, Boston Scientific Corporation, Getinge AB, Abiomed, Asahi Kasei Corporation, Berlin Heart, Carmat, Jarvik Heart Inc, Terumo Corporation, SynCardia Systems LLC, Nipro Europe Group Companies
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ARTIFICIAL ORGANS MARKET: BY ORGAN TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Organ Type
  • 4.2. Artificial Heart Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Prosthetic Heart Valves Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Ventricular Assist Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Cardiac Pacemakers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Artificial Kidney Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Artificial Pancreas Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.8. Artificial Lungs Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.9. Cochlear Implants Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.10. Artificial Liver Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.11. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ARTIFICIAL ORGANS MARKET: BY MATERIAL TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Material Type
  • 5.2. Silicon Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Plastics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Steel Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ARTIFICIAL ORGANS MARKET: BY TYPE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Type
  • 6.2. Permanent Artificial Organs Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Temporary Artificial Organs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ARTIFICIAL ORGANS MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Organ Type
    • 7.2.2 By Material Type
    • 7.2.3 By Type
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Organ Type
    • 7.3.2 By Material Type
    • 7.3.3 By Type
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Organ Type
    • 7.4.2 By Material Type
    • 7.4.3 By Type
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Organ Type
    • 7.5.2 By Material Type
    • 7.5.3 By Type
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Organ Type
    • 7.6.2 By Material Type
    • 7.6.3 By Type
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ARTIFICIAL ORGANS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 B. Braun SE
    • 9.2.2 Boston Scientific Corporation
    • 9.2.3 Getinge AB
    • 9.2.4 Abiomed
    • 9.2.5 Asahi Kasei Corporation
    • 9.2.6 Berlin Heart
    • 9.2.7 Carmat
    • 9.2.8 Jarvik Heart Inc
    • 9.2.9 Terumo Corporation
    • 9.2.10 SynCardia Systems LLC
    • 9.2.11 Nipro Europe Group Companies